SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GZMO

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (119)10/18/1999 11:31:00 AM
From: jeffbas  Read Replies (2) of 438
 
I can hardly contain myself. Now we have a real company with broader/deeper science and real money.

Furthermore, note that the additional shares that GENZ now has will be disposed of to financial or strategic investors, or in a public offering in 2000. Distribution as a dividend to existing GENZ shareholders as before is the last resort, thereby reducing the risk of the institutional dumping we had before. Guess what would happen to the price of GZMO if someone like Japan Tobacco or some US pharmaceutical company bought these shares? I would bet that is the first choice from GZMO point of view.

In my opinion, when you compare the science and the cash positions it is hard not to believe that GZMO now should have a higher market cap than ENMD.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext